Bivariate power Lomax distribution with medical applications.

PLoS One

Department of Statistical, Faculty of Business Administration, Delta University for Science and Technology, Gamasa, Egypt.

Published: March 2023

In this paper, a bivariate power Lomax distribution based on Farlie-Gumbel-Morgenstern (FGM) copulas and univariate power Lomax distribution is proposed, which is referred to as BFGMPLx. It is a significant lifetime distribution for modeling bivariate lifetime data. The statistical properties of the proposed distribution, such as conditional distributions, conditional expectations, marginal distributions, moment-generating functions, product moments, positive quadrant dependence property, and Pearson's correlation, have been studied. The reliability measures, such as the survival function, hazard rate function, mean residual life function, and vitality function, have also been discussed. The parameters of the model can be estimated through maximum likelihood and Bayesian estimation. Additionally, asymptotic confidence intervals and credible intervals of Bayesian's highest posterior density are computed for the parameter model. Monte Carlo simulation analysis is used to estimate both the maximum likelihood and Bayesian estimators.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994725PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0282581PLOS

Publication Analysis

Top Keywords

power lomax
12
lomax distribution
12
bivariate power
8
maximum likelihood
8
likelihood bayesian
8
distribution
5
distribution medical
4
medical applications
4
applications paper
4
paper bivariate
4

Similar Publications

Article Synopsis
  • Many statistical and machine learning models for binary data assume that the data is well-balanced, which can lead to inaccurate predictions when it’s not.
  • To solve this issue, researchers suggest using asymmetric link functions in binary regression instead of traditional ones like logit or probit.
  • This study introduces new classification functions based on the Lomax distribution, showing that these models, particularly the reverse power double Lomax, outperform traditional methods in handling imbalanced data, providing clearer differentiation in predictive probabilities.
View Article and Find Full Text PDF
Article Synopsis
  • A clinical trial called RADICALS-HD studied the effects of adding short-course androgen deprivation therapy (ADT) to postoperative radiotherapy in patients with localized prostate cancer after surgery.
  • It involved 1480 patients, examining how ADT impacts metastasis-free survival compared to radiotherapy alone, and measured outcomes like distant metastasis and overall survival.
  • The trial aimed to see if combining ADT with radiotherapy could improve the 10-year metastasis-free survival rate, potentially increasing it from 80% to 86%.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and optimal duration of androgen deprivation therapy (ADT) combined with postoperative radiotherapy for patients with localized prostate cancer following radical prostatectomy.
  • A randomised controlled trial, RADICALS-HD, compared short-course ADT (6 months) to long-course ADT (24 months) among participants who met specific criteria, including PSA levels and absence of metastatic disease.
  • The primary outcome measured was metastasis-free survival, with the trial aiming to determine if longer ADT duration leads to better survival rates, involving over 1,500 patients from 2008 to 2015.
View Article and Find Full Text PDF

In this study, a new four-parameter Lomax distribution is proposed using a new alpha power transformation technique. The new distribution is named "New Alpha Power Transformed Power Lomax Distribution." Mathematical properties, including moments, the moment-generating function, the mean residual life, order statistics, and the quantile function, are obtained.

View Article and Find Full Text PDF

Range uncertainties remain a limitation for the confined dose distribution that proton therapy can offer. The uncertainty stems from the ambiguity when translating CT Hounsfield Units (HU) into proton stopping powers. Proton Radiography (PR) can be used to verify the proton range.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!